
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Vertex Pharmaceuticals (United Kingdom), United Kingdom, covering academic research published from 2001 to 2024. Read More.
Open Access Percentage
49%
Total
Publications
222
Total Open
Publications
109
Total
Citations
8.7K
Open Access
Percentage
49%
Total
Publications
222
Total Open
Publications
109
Total
Citations
8.7K
Breakdown
Publisher Open
14%
Both
27%
Other Platform Open
8%
Closed
51%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 45%
40
Hybrid 34%
30
No Guarantees 21%
19
Other Platform Open
Domain 70%
54
Institution 27%
21
Other Internet 21%
16
Preprint 8%
6
Public 5%
4
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 54 |
DOI | Other Internet | 16 |
Europe PMC | Domain | 5 |
bioRxiv | Preprint | 5 |
University of Nottingham | Institution | 4 |
Imperial College London | Institution | 4 |
Figshare | Public | 4 |
University of Oxford | Institution | 3 |
Office of Scientific and Technical Information | Institution | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 2 |